4//SEC Filing
Ajer Jeffrey Robert 4
Accession 0001048477-24-000073
CIK 0001048477other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 4:40 PM ET
Size
6.4 KB
Accession
0001048477-24-000073
Insider Transaction Report
Form 4
Ajer Jeffrey Robert
SVP, Chief Commercial Of
Transactions
- Award
Common Stock
2024-04-30$68.65/sh+300$20,594→ 71,767 total - Sale
Common Stock
2024-05-02$82.91/sh−5,000$414,550→ 66,767 total
Footnotes (2)
- [F1]Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan.
- [F2]Trade made pursuant to a 10b5-1 plan executed on April 13, 2023.
Documents
Issuer
BIOMARIN PHARMACEUTICAL INC
CIK 0001048477
Entity typeother
Related Parties
1- filerCIK 0001557533
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 4:40 PM ET
- Size
- 6.4 KB